// App-Quantinova.ai

4369 : Practical Experience of Thromboprophylaxis After Lower Limb Replacement Rivaroxaban Versus Enoxaparin

Researchers

Presenter

  • Kyoung Ha Kim

Principal Investigators

  • Nam Seok Ham

  • Yang Ki Kim

  • Hyung Suk Choi

  • You Sung Suh

  • Young Woo Jeon

  • Han Jo Kim

  • Se Hyung Kim

  • Sang Byung Bae

  • Sung Kyu Park

  • Jong-Ho Won

  • Dae Sik Hong

  • Hee Sook Park

Medical Centers

  • Department of Internal Medicine, Soonchunhang University Hospital, Cheonan, South Korea,

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Deep vein thrombosis

  • Renal insufficiency

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim